$OPEN
Opendoor Technologies Inc. Stock $open

$open Overview Financials Valuation SEC Filings Company Website

2021 Q2 Form 10-Q Financial Statement

#000180116921000101 Filed on August 11, 2021

Income Statement

Concept	2021 Q2	2020 Q4	2020 Q2
Revenue	$1.186B	$248.9M	$739.8M
YoY Change	60.31%	-80.18%	-41.3%
Cost Of Revenue	$1.027B	$210.5M	$685.3M
YoY Change	49.87%	-82.19%
Gross Profit	$159.0M	$38.37M	$54.57M
YoY Change	191.35%	-48.13%	-33.08%
Gross Profit Margin	13.41%	15.41%	7.38%
Selling, General & Admin	$287.0M	$92.10M	$76.59M
YoY Change	274.73%	-26.73%
% of Gross Profit	180.5%	240.06%	140.34%
Research & Development	$24.00M	$12.40M	$16.84M
YoY Change	42.53%	-11.43%
% of Gross Profit	15.09%	32.32%	30.85%
Depreciation & Amortization	$6.000M	$7.500M	$5.900M
YoY Change	1.69%	-15.73%
% of Gross Profit	3.77%	19.55%	10.81%
Operating Expenses	$311.0M	$104.5M	$93.43M
YoY Change	232.88%	-25.2%
Operating Profit	-$152.0M	-$66.13M	-$38.85M
YoY Change	291.23%	0.6%
Interest Expense	$16.00M	-$11.10M	$17.29M
YoY Change	-7.46%	-61.72%
% of Operating Profit
Other Income/Expense, Net	$0.00	$700.0K	$180.0K
YoY Change	-100.0%	-76.67%
Pretax Income	-$144.0M	-$88.00M	-$55.84M
YoY Change	157.88%	-4.14%
Income Tax	$200.0K	-$200.0K	$100.0K
% Of Pretax Income
Net Earnings	-$144.0M	-$87.79M	-$55.92M
YoY Change	157.52%	-4.28%	-25.58%
Net Earnings / Revenue	-12.14%	-35.27%	-7.56%
Basic Earnings Per Share	-$0.24	-$0.49	-$0.66
Diluted Earnings Per Share	-$0.24	-$0.49	-$0.66
COMMON SHARES
Basic Shares Outstanding	588.4M shares		84.59M shares
Diluted Shares Outstanding	588.4M shares		84.59M shares

Balance Sheet

Concept	2021 Q2	2020 Q4	2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.758B	$1.461B
YoY Change		225.62%
Cash & Equivalents	$1.558B	$1.413B	$458.1M
Short-Term Investments	$200.1M	$47.64M
Other Short-Term Assets	$67.15M	$24.00M
YoY Change		-22.28%
Inventory	$2.724B	$465.9M
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$4.739B	$2.053B
YoY Change		-1.66%
LONG-TERM ASSETS
Property, Plant & Equipment	$33.96M	$29.00M
YoY Change		-16.2%
Goodwill	$30.95M	$31.00M
YoY Change		0.18%
Intangibles	$7.754M	$9.000M
YoY Change		-27.5%
Long-Term Investments
YoY Change
Other Assets	$11.40M	$4.000M
YoY Change		-25.84%
Total Long-Term Assets	$129.6M	$123.0M
YoY Change		-14.61%
TOTAL ASSETS
Total Short-Term Assets	$4.739B	$2.053B
Total Long-Term Assets	$129.6M	$123.0M
Total Assets	$4.868B	$2.176B
YoY Change		-2.5%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$70.90M	$2.800M
YoY Change
Accrued Expenses	$9.604M	$11.00M
YoY Change		-32.69%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$1.691B	$346.3M
YoY Change		-67.76%
Total Short-Term Liabilities	$1.810B	$393.0M
YoY Change		-65.11%
LONG-TERM LIABILITIES
Long-Term Debt	$595.6M	$135.5M
YoY Change
Other Long-Term Liabilities	$117.0K	$94.00K
YoY Change		-54.81%
Total Long-Term Liabilities	$117.0K	$94.00K
YoY Change		-54.81%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.810B	$393.0M
Total Long-Term Liabilities	$117.0K	$94.00K
Total Liabilities	$2.450B	$623.0M
YoY Change		-60.65%
SHAREHOLDERS EQUITY
Retained Earnings	-$1.458B	-$1.043B
YoY Change		31.94%
Common Stock	$59.00K	$0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$2.418B	$1.600B
YoY Change
Total Liabilities & Shareholders Equity	$4.868B	$2.176B
YoY Change		-2.5%

Cashflow Statement

Concept	2021 Q2	2020 Q4	2020 Q2
OPERATING ACTIVITIES
Net Income	-$144.0M	-$87.79M	-$55.92M
YoY Change	157.52%	-4.28%	-25.58%
Depreciation, Depletion And Amortization	$6.000M	$7.500M	$5.900M
YoY Change	1.69%	-15.73%
Cash From Operating Activities	-$1.907B	-$355.5M
YoY Change		-973.46%
INVESTING ACTIVITIES
Capital Expenditures	-$7.097M	-$5.200M
YoY Change		-16.13%
Acquisitions
YoY Change
Other Investing Activities	-$141.7M	$34.30M
YoY Change		-468.82%
Cash From Investing Activities	-$148.7M	$28.90M
YoY Change		-286.45%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.562B	1.189B
YoY Change		31176.32%
NET CHANGE
Cash From Operating Activities	-1.907B	-355.5M
Cash From Investing Activities	-148.7M	28.90M
Cash From Financing Activities	1.562B	1.189B
Net Change In Cash	-493.8M	861.9M
YoY Change		2872.07%
FREE CASH FLOW
Cash From Operating Activities	-$1.907B	-$355.5M
Capital Expenditures	-$7.097M	-$5.200M
Free Cash Flow	-$1.900B	-$350.3M
YoY Change		-846.91%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0001801169
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	open	Class Of Warrant Or Right Trading Day Period Used To Determine Reference Value On The Last Reported Sales Price Of Common Stock ClassOfWarrantOrRightTradingDayPeriodUsedToDetermineReferenceValueOnTheLastReportedSalesPriceOfCommonStock	P30D
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2021-06-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-39253
	dei	Entity Registrant Name EntityRegistrantName	Opendoor Technologies Inc.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	98-1515020
	dei	Entity Address Address Line1 EntityAddressAddressLine1	410 N. Scottsdale Road,
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 1600
	dei	Entity Address City Or Town EntityAddressCityOrTown	Tempe,
	dei	Entity Address State Or Province EntityAddressStateOrProvince	AZ
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	85281
	dei	City Area Code CityAreaCode	415
	dei	Local Phone Number LocalPhoneNumber	896-6737
	dei	Security12b Title Security12bTitle	Common stock, $0.0001 par value per share
	dei	Trading Symbol TradingSymbol	OPEN
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2021Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	604641158	shares
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1557815000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1412665000	USD
CY2021Q2	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	131652000	USD
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	92863000	USD
CY2021Q2	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	200143000	USD
CY2020Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	47637000	USD
CY2021Q2	us-gaap	Pledged Assets Separately Reported Mortgage Related Securities Available For Sale Or Held For Investment PledgedAssetsSeparatelyReportedMortgageRelatedSecuritiesAvailableForSaleOrHeldForInvestment	25368000	USD
CY2020Q4	us-gaap	Pledged Assets Separately Reported Mortgage Related Securities Available For Sale Or Held For Investment PledgedAssetsSeparatelyReportedMortgageRelatedSecuritiesAvailableForSaleOrHeldForInvestment	7529000	USD
CY2021Q2	us-gaap	Escrow Deposit EscrowDeposit	32848000	USD
CY2020Q4	us-gaap	Escrow Deposit EscrowDeposit	1494000	USD
CY2021Q2	us-gaap	Inventory Real Estate InventoryRealEstate	2723648000	USD
CY2020Q4	us-gaap	Inventory Real Estate InventoryRealEstate	465936000	USD
CY2021Q2	open	Other Assets Current Fair Value Disclosure OtherAssetsCurrentFairValueDisclosure	811000	USD
CY2020Q4	open	Other Assets Current Fair Value Disclosure OtherAssetsCurrentFairValueDisclosure	373000	USD
CY2021Q2	us-gaap	Other Assets Current OtherAssetsCurrent	67149000	USD
CY2020Q4	us-gaap	Other Assets Current OtherAssetsCurrent	24987000	USD
CY2021Q2	us-gaap	Assets Current AssetsCurrent	4738623000	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	2053111000	USD
CY2021Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	33962000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	29228000	USD
CY2021Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	45581000	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	49517000	USD
CY2021Q2	us-gaap	Goodwill Goodwill	30945000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	30945000	USD
CY2021Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	7754000	USD
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	8684000	USD
CY2021Q2	open	Other Assets Noncurrent Fair Value Disclosure OtherAssetsNoncurrentFairValueDisclosure	10000000	USD
CY2020Q4	open	Other Assets Noncurrent Fair Value Disclosure OtherAssetsNoncurrentFairValueDisclosure	0	USD
CY2021Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	11396000	USD
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	4097000	USD
CY2021Q2	us-gaap	Assets Assets	4868261000	USD
CY2020Q4	us-gaap	Assets Assets	2175582000	USD
CY2021Q2	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	70900000	USD
CY2020Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	25270000	USD
CY2021Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	1690878000	USD
CY2020Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	346322000	USD
CY2021Q2	open	Warrants And Rights Outstanding Current WarrantsAndRightsOutstandingCurrent	38669000	USD
CY2020Q4	open	Warrants And Rights Outstanding Current WarrantsAndRightsOutstandingCurrent	0	USD
CY2021Q2	us-gaap	Interest Payable Current InterestPayableCurrent	4605000	USD
CY2020Q4	us-gaap	Interest Payable Current InterestPayableCurrent	1081000	USD
CY2021Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	4999000	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	20716000	USD
CY2021Q2	us-gaap	Liabilities Current LiabilitiesCurrent	1810051000	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	393389000	USD
CY2021Q2	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	595579000	USD
CY2020Q4	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	135467000	USD
CY2021Q2	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	0	USD
CY2020Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	47349000	USD
CY2021Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	44593000	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	46625000	USD
CY2021Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	117000	USD
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	94000	USD
CY2021Q2	us-gaap	Liabilities Liabilities	2450340000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	622924000	USD
CY2021Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	3000000000	shares
CY2021Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	3000000000	shares
CY2021Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	593838919	shares
CY2021Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	593838919	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	540714692	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	540714692	shares
CY2021Q2	us-gaap	Common Stock Value CommonStockValue	59000	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	54000	USD
CY2021Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	3875552000	USD
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	2596012000	USD
CY2021Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1457690000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1043449000	USD
CY2021Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	0	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	41000	USD
CY2021Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2417921000	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1552658000	USD
CY2021Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4868261000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2175582000	USD
CY2021Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1185386000	USD
CY2020Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	739827000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1932660000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1995622000	USD
CY2021Q2	us-gaap	Cost Of Revenue CostOfRevenue	1026615000	USD
CY2020Q2	us-gaap	Cost Of Revenue CostOfRevenue	685253000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	1676757000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	1850001000	USD
CY2021Q2	us-gaap	Gross Profit GrossProfit	158771000	USD
CY2020Q2	us-gaap	Gross Profit GrossProfit	54574000	USD
	us-gaap	Gross Profit GrossProfit	255903000	USD
	us-gaap	Gross Profit GrossProfit	145621000	USD
CY2021Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	96525000	USD
CY2020Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	47265000	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	165591000	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	128954000	USD
CY2021Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	190611000	USD
CY2020Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	29323000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	412695000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	58906000	USD
CY2021Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	24388000	USD
CY2020Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	16838000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	75065000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	32625000	USD
CY2021Q2	us-gaap	Operating Expenses OperatingExpenses	311524000	USD
CY2020Q2	us-gaap	Operating Expenses OperatingExpenses	93426000	USD
	us-gaap	Operating Expenses OperatingExpenses	653351000	USD
	us-gaap	Operating Expenses OperatingExpenses	220485000	USD
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-152753000	USD
CY2020Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-38852000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-397448000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-74864000	USD
CY2021Q2	open	Fair Value Adjustment Of Warrants And Derivative Liabilities FairValueAdjustmentOfWarrantsAndDerivativeLiabilities	-23952000	USD
CY2020Q2	open	Fair Value Adjustment Of Warrants And Derivative Liabilities FairValueAdjustmentOfWarrantsAndDerivativeLiabilities	-122000	USD
	open	Fair Value Adjustment Of Warrants And Derivative Liabilities FairValueAdjustmentOfWarrantsAndDerivativeLiabilities	-8680000	USD
	open	Fair Value Adjustment Of Warrants And Derivative Liabilities FairValueAdjustmentOfWarrantsAndDerivativeLiabilities	890000	USD
CY2021Q2	us-gaap	Interest Expense InterestExpense	15826000	USD
CY2020Q2	us-gaap	Interest Expense InterestExpense	17290000	USD
	us-gaap	Interest Expense InterestExpense	26825000	USD
	us-gaap	Interest Expense InterestExpense	45017000	USD
CY2021Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1012000	USD
CY2020Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	180000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1636000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2855000	USD
CY2021Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-143615000	USD
CY2020Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-55840000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-413957000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-117916000	USD
CY2021Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	190000	USD
CY2020Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	79000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	284000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	199000	USD
CY2021Q2	us-gaap	Profit Loss ProfitLoss	-143805000	USD
CY2020Q2	us-gaap	Profit Loss ProfitLoss	-55919000	USD
	us-gaap	Profit Loss ProfitLoss	-414241000	USD
	us-gaap	Profit Loss ProfitLoss	-118115000	USD
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.24
CY2020Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.66
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.72
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.40
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.24
CY2020Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.66
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.72
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.40
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	588374000	shares
CY2020Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	84588000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	576941000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	84308000	shares
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	588374000	shares
CY2020Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	84588000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	576941000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	84308000	shares
CY2021Q2	us-gaap	Profit Loss ProfitLoss	-143805000	USD
CY2020Q2	us-gaap	Profit Loss ProfitLoss	-55919000	USD
	us-gaap	Profit Loss ProfitLoss	-414241000	USD
	us-gaap	Profit Loss ProfitLoss	-118115000	USD
CY2021Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-6000	USD
CY2020Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	583000	USD
CY2021Q2	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-143811000	USD
CY2020Q2	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-55336000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-41000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	284000	USD
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-414282000	USD
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-117831000	USD
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2383561000	USD
CY2021Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	-28000	USD
CY2021Q2	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	5801000	USD
CY2021Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	6471000	USD
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	165898000	USD
CY2021Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-6000	USD
CY2021Q2	us-gaap	Profit Loss ProfitLoss	-143805000	USD
CY2021Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2417921000	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1552658000	USD
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	857194000	USD
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	5801000	USD
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	6737000	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	409767000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-41000	USD
	us-gaap	Profit Loss ProfitLoss	-414241000	USD
CY2021Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2417921000	USD
CY2020Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-792166000	USD
CY2020Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	38000	USD
CY2020Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	275000	USD
CY2020Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3670000	USD
CY2020Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	583000	USD
CY2020Q2	us-gaap	Profit Loss ProfitLoss	-55919000	USD
CY2020Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-843519000	USD
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-733103000	USD
	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	74000	USD
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	701000	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	6640000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	284000	USD
	us-gaap	Profit Loss ProfitLoss	-118115000	USD
CY2020Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-843519000	USD
	us-gaap	Profit Loss ProfitLoss	-414241000	USD
	us-gaap	Profit Loss ProfitLoss	-118115000	USD
	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	16608000	USD
	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	20065000	USD
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	4260000	USD
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	8712000	USD
	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	2515000	USD
	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	0	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	403048000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	6640000	USD
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-8680000	USD
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	890000	USD
	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	5237000	USD
	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	0	USD
	us-gaap	Inventory Write Down InventoryWriteDown	942000	USD
	us-gaap	Inventory Write Down InventoryWriteDown	7452000	USD
	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	438000	USD
	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	527000	USD
	us-gaap	Paid In Kind Interest PaidInKindInterest	0	USD
	us-gaap	Paid In Kind Interest PaidInKindInterest	2704000	USD
	open	Dividend In Kind DividendInKind	143000	USD
	open	Dividend In Kind DividendInKind	0	USD
	open	Net Fair Value Adjustments And Gain Loss On Sale Of Mortgage Loans Held For Sale NetFairValueAdjustmentsAndGainLossOnSaleOfMortgageLoansHeldForSale	2032000	USD
	open	Net Fair Value Adjustments And Gain Loss On Sale Of Mortgage Loans Held For Sale NetFairValueAdjustmentsAndGainLossOnSaleOfMortgageLoansHeldForSale	829000	USD
	us-gaap	Payments For Origination And Purchases Of Loans Held For Sale PaymentsForOriginationAndPurchasesOfLoansHeldForSale	83360000	USD
	us-gaap	Payments For Origination And Purchases Of Loans Held For Sale PaymentsForOriginationAndPurchasesOfLoansHeldForSale	42636000	USD
	us-gaap	Proceeds From Sale And Collection Of Loans Heldforsale ProceedsFromSaleAndCollectionOfLoansHeldforsale	67566000	USD
	us-gaap	Proceeds From Sale And Collection Of Loans Heldforsale ProceedsFromSaleAndCollectionOfLoansHeldforsale	34397000	USD
	open	Increase Decrease In Escrow Receivable IncreaseDecreaseInEscrowReceivable	31354000	USD
	open	Increase Decrease In Escrow Receivable IncreaseDecreaseInEscrowReceivable	-4178000	USD
	us-gaap	Increase Decrease In Mortgage Loans Held For Sale IncreaseDecreaseInMortgageLoansHeldForSale	2249488000	USD
	us-gaap	Increase Decrease In Mortgage Loans Held For Sale IncreaseDecreaseInMortgageLoansHeldForSale	-1035088000	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	37057000	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-10809000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	34569000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-8881000	USD
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	96000	USD
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-3044000	USD
	open	Increase Decrease In Lease Liabilities IncreaseDecreaseInLeaseLiabilities	-9968000	USD
	open	Increase Decrease In Lease Liabilities IncreaseDecreaseInLeaseLiabilities	-6556000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2312108000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	950347000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	10957000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	10753000	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	240000	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	0	USD
	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	238464000	USD
	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	113833000	USD
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	85638000	USD
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	55666000	USD
	open	Payments To Acquire Equity Securities Fvni PaymentsToAcquireEquitySecuritiesFVNI	10000000	USD
	open	Payments To Acquire Equity Securities Fvni PaymentsToAcquireEquitySecuritiesFVNI	0	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-174023000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-68920000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	6739000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	688000	USD
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	4823000	USD
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	886067000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	28876000	USD
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	USD
	open	Proceeds From Credit Facilities And Other Secured Borrowings ProceedsFromCreditFacilitiesAndOtherSecuredBorrowings	3241692000	USD
	open	Proceeds From Credit Facilities And Other Secured Borrowings ProceedsFromCreditFacilitiesAndOtherSecuredBorrowings	824597000	USD
	open	Principal Payments On Credit Facilities And Other Secured Borrowings PrincipalPaymentsOnCreditFacilitiesAndOtherSecuredBorrowings	1438136000	USD
	open	Principal Payments On Credit Facilities And Other Secured Borrowings PrincipalPaymentsOnCreditFacilitiesAndOtherSecuredBorrowings	1723443000	USD
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	2239000	USD
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	2386000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2670070000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-900544000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	183939000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-19117000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1505528000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	684822000	USD
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1689467000	USD
CY2020Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	665705000	USD
	us-gaap	Interest Paid Net InterestPaidNet	20526000	USD
	us-gaap	Interest Paid Net InterestPaidNet	40333000	USD
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1557815000	USD
CY2020Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	458058000	USD
CY2021Q2	us-gaap	Restricted Cash RestrictedCash	131652000	USD
CY2020Q2	us-gaap	Restricted Cash RestrictedCash	207647000	USD
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1689467000	USD
CY2020Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	665705000	USD
	open	Number Of Home Transactions Completed NumberOfHomeTransactionsCompleted	100000	home
	open	Number Of Currently Operated Markets NumberOfCurrentlyOperatedMarkets	39	market
CY2020Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	47349000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	622924000	USD
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	2596012000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1043449000	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1552658000	USD
	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results may differ materially from such estimates. Significant estimates, assumptions and judgments made by management include, among others, the determination of the fair value of common stock, share-based awards, warrants, derivatives, convertible notes, and inventory impairment (“real estate inventory valuation adjustment”). Management believes that the estimates and judgments upon which they rely are reasonable based upon information available to them at the time that these estimates and judgments are made. To the extent that there are material differences between these estimates and actual results, the Company’s financial statements will be affected. The COVID-19 pandemic introduced significant additional uncertainties with respect to estimates, judgments and assumptions, which may materially impact these estimates.</span></div>
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentrations of Credit Risk</span></div><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments, which potentially subject the Company to concentrations of credit risk, consist primarily of cash and cash equivalents, investments in marketable securities, and mortgage loans held for sale pledged under agreements to repurchase (“MLHFS”). The Company places cash and cash equivalents and investments with major financial institutions, which management assesses to be of high credit quality, in order to limit exposure of the Company’s investments.</span></div>Similarly, the Company’s credit risk on mortgage loans held for sale is mitigated due to a large number of customers. Further, the Company’s credit risk on mortgage loans held for sale is mitigated by the fact that the Company typically sells mortgages on the secondary market within a relatively short period of time after which the Company’s exposure is limited to borrower defaults within the initial few months of the mortgage.
CY2021Q2	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	900000	USD
	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	3500000	USD
	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	1800000	USD
CY2020Q2	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	1800000	USD
CY2020Q4	open	Business Combination Consideration Transferred Stock Issued Conversion Ratio BusinessCombinationConsiderationTransferredStockIssuedConversionRatio	1
CY2021Q2	us-gaap	Inventory Real Estate Construction In Process InventoryRealEstateConstructionInProcess	1025954000	USD
CY2020Q4	us-gaap	Inventory Real Estate Construction In Process InventoryRealEstateConstructionInProcess	183004000	USD
CY2021Q2	open	Inventory Real Estate Finished Goods InventoryRealEstateFinishedGoods	1697694000	USD
CY2020Q4	open	Inventory Real Estate Finished Goods InventoryRealEstateFinishedGoods	282932000	USD
CY2021Q2	us-gaap	Inventory Real Estate InventoryRealEstate	2723648000	USD
CY2020Q4	us-gaap	Inventory Real Estate InventoryRealEstate	465936000	USD
CY2021Q2	open	Cash Cash Equivalents And Available For Sale Debt Securities Amortized Cost CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost	1757958000	USD
CY2021Q2	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	0	USD
CY2021Q2	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	0	USD
CY2021Q2	open	Cash Cash Equivalents And Available For Sale Debt Securities CashCashEquivalentsAndAvailableForSaleDebtSecurities	1757958000	USD
CY2021Q2	open	Debt Securities Available For Sale Cash And Cash Equivalents DebtSecuritiesAvailableForSaleCashAndCashEquivalents	1557815000	USD
CY2021Q2	open	Debt Securities Available For Sale Marketable Securities DebtSecuritiesAvailableForSaleMarketableSecurities	200143000	USD
CY2021Q2	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	10000000.0	USD
CY2020Q4	open	Cash Cash Equivalents And Available For Sale Debt Securities Amortized Cost CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost	1460260000	USD
CY2020Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	48000	USD
CY2020Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	6000	USD
CY2020Q4	open	Cash Cash Equivalents And Available For Sale Debt Securities CashCashEquivalentsAndAvailableForSaleDebtSecurities	1460302000	USD
CY2020Q4	open	Debt Securities Available For Sale Cash And Cash Equivalents DebtSecuritiesAvailableForSaleCashAndCashEquivalents	1412665000	USD
CY2020Q4	open	Debt Securities Available For Sale Marketable Securities DebtSecuritiesAvailableForSaleMarketableSecurities	47637000	USD
CY2021Q2	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	0	USD
CY2020Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	31445000	USD
CY2020Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	6000	USD
CY2020Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	0	USD
CY2020Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	0	USD
CY2020Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	31445000	USD
CY2020Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	6000	USD
CY2020	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	0	USD
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2021Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	449000000	USD
CY2021Q2	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	449000000	USD
CY2021Q2	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	3154000	USD
CY2021Q2	us-gaap	Long Term Debt LongTermDebt	445846000	USD
CY2021Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	77021000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	63486000	USD
CY2021Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	43059000	USD
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	34258000	USD
CY2021Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	33962000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	29228000	USD
CY2021Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	6100000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	11700000	USD
CY2020Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	5900000	USD
	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	0	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	10900000	USD
CY2021Q2	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2020Q2	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2021Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	16061000	USD
CY2021Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	8466000	USD
CY2021Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	7595000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	15821000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	7295000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	8526000	USD
CY2020Q4	us-gaap	Indefinite Lived Trade Names IndefiniteLivedTradeNames	200000	USD
CY2021Q2	us-gaap	Indefinite Lived Trade Names IndefiniteLivedTradeNames	200000	USD
CY2021Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	600000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1200000	USD
CY2020Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1100000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2200000	USD
CY2021Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	1281000	USD
CY2021Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	2428000	USD
CY2021Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	2320000	USD
CY2021Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	1566000	USD
CY2021Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	7595000	USD
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	24158000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	4242000	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.91
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y4M24D
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	502767000	USD
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.63
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	173000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	2.72
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	2000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	3.02
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	19741000	shares
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.84
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	310914000	USD
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	16305000	shares
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	1.66
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P4Y6M
CY2021Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	261938000	USD
CY2021Q2	open	Class Of Warrant Or Right Reference Value ClassOfWarrantOrRightReferenceValue	18.00
CY2021Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	11.50
CY2021Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	164216000	USD
CY2020Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3670000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	403048000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	6640000	USD
CY2020Q2	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight	1	shares
CY2020Q2	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P5Y
	open	Class Of Warrants And Rights Redemption Price Per Share ClassOfWarrantsAndRightsRedemptionPricePerShare	0.01
CY2021Q2	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	19933333	shares
CY2021Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	19400000	shares
CY2021Q2	open	Class Of Warrant Or Right Exercised ClassOfWarrantOrRightExercised	500000	shares
CY2021Q2	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-24000000.0	USD
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-8700000	USD
CY2021Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	200000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	300000	USD
CY2021Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.0013
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.0007
CY2020Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	100000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	200000	USD
CY2020Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.0014
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.0017
	us-gaap	Dividends Dividends	0	USD
CY2021Q2	us-gaap	Dividends Dividends	0	USD
	us-gaap	Dividends Dividends	0	USD
CY2020Q2	us-gaap	Dividends Dividends	0	USD
CY2021Q2	us-gaap	Profit Loss ProfitLoss	-143805000	USD
CY2020Q2	us-gaap	Profit Loss ProfitLoss	-55919000	USD
	us-gaap	Profit Loss ProfitLoss	-414241000	USD
	us-gaap	Profit Loss ProfitLoss	-118115000	USD
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	588374000	shares
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	588374000	shares
CY2020Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	84588000	shares
CY2020Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	84588000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	576941000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	576941000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	84308000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	84308000	shares
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.24
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.24
CY2020Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.66
CY2020Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.66
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.72
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.72
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.40
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.40
CY2021Q2	us-gaap	Dividends Preferred Stock DividendsPreferredStock	0	USD
CY2021Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	96263000	shares
CY2020Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	379929000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	96263000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	379929000	shares
CY2021Q2	us-gaap	Recorded Unconditional Purchase Obligation Minimum Quantity Required RecordedUnconditionalPurchaseObligationMinimumQuantityRequired	8158	home
CY2021Q2	us-gaap	Recorded Unconditional Purchase Obligation RecordedUnconditionalPurchaseObligation	2962300000	USD
	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	5200000	USD

Files In Submission

Name	View Source	Status
0001801169-21-000101-index-headers.html	Edgar Link	pending
0001801169-21-000101-index.html	Edgar Link	pending
0001801169-21-000101.txt	Edgar Link	pending
0001801169-21-000101-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
open-20210630.htm	Edgar Link	pending
open-20210630.xsd	Edgar Link	pending
open-20210630_cal.xml	Edgar Link	unprocessable
open-20210630_def.xml	Edgar Link	unprocessable
open-20210630_htm.xml	Edgar Link	completed
open-20210630_lab.xml	Edgar Link	unprocessable
open-20210630_pre.xml	Edgar Link	unprocessable
q22021ex101formofrsugrantn.htm	Edgar Link	pending
q22021exhibit311.htm	Edgar Link	pending
q22021exhibit312.htm	Edgar Link	pending
q22021exhibit321.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$OPEN
Opendoor Technologies Inc. Stock $open

2021 Q2 Form 10-Q Financial Statement

#000180116921000101 Filed on August 11, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OPEN Opendoor Technologies Inc. Stock $open

2021 Q2 Form 10-Q Financial Statement

#000180116921000101 Filed on August 11, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OPEN
Opendoor Technologies Inc. Stock $open